Addex Therapeutics (ADXN) Other Working Capital Changes (2022 - 2025)
Historic Other Working Capital Changes for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to $193.1 billion.
- Addex Therapeutics' Other Working Capital Changes fell 5982.36% to $193.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $12.9 billion, marking a year-over-year decrease of 9841.38%. This contributed to the annual value of -$186741.9 for FY2024, which is 41415.67% down from last year.
- Latest data reveals that Addex Therapeutics reported Other Working Capital Changes of $193.1 billion as of Q2 2025, which was down 5982.36% from -$177.8 billion recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Other Working Capital Changes ranged from a high of $480.5 billion in Q2 2024 and a low of -$815.3 billion during Q2 2023
- Over the past 4 years, Addex Therapeutics' median Other Working Capital Changes value was $341877.7 (recorded in 2022), while the average stood at $608.8 million.
- Data for Addex Therapeutics' Other Working Capital Changes shows a peak YoY increase of 6835027257.35% (in 2023) and a maximum YoY decrease of 70478289808.47% (in 2023) over the last 5 years.
- Over the past 4 years, Addex Therapeutics' Other Working Capital Changes (Quarter) stood at $568069.9 in 2022, then soared by 68350272.57% to $388.3 billion in 2023, then crashed by 43.86% to $218.0 billion in 2024, then dropped by 11.44% to $193.1 billion in 2025.
- Its Other Working Capital Changes was $193.1 billion in Q2 2025, compared to -$177.8 billion in Q1 2025 and $218.0 billion in Q4 2024.